Ankylosing Spondylitis and Axial Spondyloarthritis
-10%
portes grátis
Ankylosing Spondylitis and Axial Spondyloarthritis
Khan, Muhammad Asim
Oxford University Press
01/2023
224
Mole
Inglês
9780198864158
15 a 20 dias
270
Descrição não disponível.
1: What is ankylosing spondylitis?
2: What is axial spondyloarthritis?
3: What is the underlying cause? HLA-B27 and other disease predisposing genes
4: Disease prevalence
5: Early symptoms
6: Eye inflammation (acute anterior uveitis)
7: Other manifestations
8: Findings on clinical examination and laboratory tests
9: Radiology, MRI, and CT
10: Diagnosis of other forms of SpA and 'look-alikes'
11: Other causes of chronic back pain
12: Assessment of disease activity and functional impairment
13: Patient education
14: Exercise and physical therapy
15: Management: An Overview
16: Management: Patient's role
17: Management: Rheumatologist's role
18: NSAIDs and conventional DMARDs
19: Tumor Necrosis Factor Inhibitors
20: IL-17 and IL-23 inhibitors; and targeted synthetic DMARDs
21: Living with the disease and its socioeconomic impact
22: Fused (ankylosed) spine and risk of fractures
23: Surgical treatment
24: Nontraditional (complementary or alternative) therapy
25: Disease course and effect on lifespan
26: Illustrative case histories
Appendix 1: Patient support groups and organizations
Appendix 2: Glossary
Appendix 3: List of abbreviations
Appendix 4: References and further reading
2: What is axial spondyloarthritis?
3: What is the underlying cause? HLA-B27 and other disease predisposing genes
4: Disease prevalence
5: Early symptoms
6: Eye inflammation (acute anterior uveitis)
7: Other manifestations
8: Findings on clinical examination and laboratory tests
9: Radiology, MRI, and CT
10: Diagnosis of other forms of SpA and 'look-alikes'
11: Other causes of chronic back pain
12: Assessment of disease activity and functional impairment
13: Patient education
14: Exercise and physical therapy
15: Management: An Overview
16: Management: Patient's role
17: Management: Rheumatologist's role
18: NSAIDs and conventional DMARDs
19: Tumor Necrosis Factor Inhibitors
20: IL-17 and IL-23 inhibitors; and targeted synthetic DMARDs
21: Living with the disease and its socioeconomic impact
22: Fused (ankylosed) spine and risk of fractures
23: Surgical treatment
24: Nontraditional (complementary or alternative) therapy
25: Disease course and effect on lifespan
26: Illustrative case histories
Appendix 1: Patient support groups and organizations
Appendix 2: Glossary
Appendix 3: List of abbreviations
Appendix 4: References and further reading
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
1: What is ankylosing spondylitis?
2: What is axial spondyloarthritis?
3: What is the underlying cause? HLA-B27 and other disease predisposing genes
4: Disease prevalence
5: Early symptoms
6: Eye inflammation (acute anterior uveitis)
7: Other manifestations
8: Findings on clinical examination and laboratory tests
9: Radiology, MRI, and CT
10: Diagnosis of other forms of SpA and 'look-alikes'
11: Other causes of chronic back pain
12: Assessment of disease activity and functional impairment
13: Patient education
14: Exercise and physical therapy
15: Management: An Overview
16: Management: Patient's role
17: Management: Rheumatologist's role
18: NSAIDs and conventional DMARDs
19: Tumor Necrosis Factor Inhibitors
20: IL-17 and IL-23 inhibitors; and targeted synthetic DMARDs
21: Living with the disease and its socioeconomic impact
22: Fused (ankylosed) spine and risk of fractures
23: Surgical treatment
24: Nontraditional (complementary or alternative) therapy
25: Disease course and effect on lifespan
26: Illustrative case histories
Appendix 1: Patient support groups and organizations
Appendix 2: Glossary
Appendix 3: List of abbreviations
Appendix 4: References and further reading
2: What is axial spondyloarthritis?
3: What is the underlying cause? HLA-B27 and other disease predisposing genes
4: Disease prevalence
5: Early symptoms
6: Eye inflammation (acute anterior uveitis)
7: Other manifestations
8: Findings on clinical examination and laboratory tests
9: Radiology, MRI, and CT
10: Diagnosis of other forms of SpA and 'look-alikes'
11: Other causes of chronic back pain
12: Assessment of disease activity and functional impairment
13: Patient education
14: Exercise and physical therapy
15: Management: An Overview
16: Management: Patient's role
17: Management: Rheumatologist's role
18: NSAIDs and conventional DMARDs
19: Tumor Necrosis Factor Inhibitors
20: IL-17 and IL-23 inhibitors; and targeted synthetic DMARDs
21: Living with the disease and its socioeconomic impact
22: Fused (ankylosed) spine and risk of fractures
23: Surgical treatment
24: Nontraditional (complementary or alternative) therapy
25: Disease course and effect on lifespan
26: Illustrative case histories
Appendix 1: Patient support groups and organizations
Appendix 2: Glossary
Appendix 3: List of abbreviations
Appendix 4: References and further reading
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
